Abstract

BackgroundHuman adenoviruses are a frequent threat to immunocompromised patients, and disseminated disease is associated with severe morbidity and mortality. Current drugs are not capable of preventing all fatalities, thus indicating the need for alternative treatment strategies. Adenoviruses can be rendered susceptible to antiherpetic prodrugs such as ganciclovir (GCV), upon expression of the herpes simplex virus thymidine kinase (HSV-TK) gene in adenovirus-infected cells. Furthermore, adenoviruses are amenable to post-transcriptional gene silencing via small interfering RNAs (siRNAs) or artificial micro RNAs (amiRNAs).ResultsIn this study, we combined these 2 approaches by constructing a combinatorial gene expression cassette that comprises the HSV-TK gene and multiple copies of an amiRNA directed against the mRNA encoding the adenoviral preterminal protein (pTP). HSV-TK gene expression was controlled by the adenoviral E4 promoter, which is activated in the presence of the adenoviral E1 gene products (i.e., when adenovirus is present in the cell). When inserted into a replication-deficient (E1-, E3-deleted) adenoviral vector, this cassette effectively inhibited the replication of wild-type adenovirus in vitro. The reduction rate mediated by the combinatorial approach was higher compared to that achieved by either of the 2 approaches alone, and these obvious additive effects became most pronounced when the GCV concentration was low.ConclusionsThe concept presented here has the potential to aid in the inhibition of wild-type adenovirus replication. Furthermore, the combinatorial expression cassette may constitute a safeguard to potentially control unintended replication of adenoviral vectors and to prevent immune responses provoked by them.

Highlights

  • Human adenoviruses are a frequent threat to immunocompromised patients, and disseminated disease is associated with severe morbidity and mortality

  • Adenovirus-directed small interfering RNAs (siRNAs) increase the herpes simplex virus thymidine kinase (HSV-TK)/GCVmediated anti-adenoviral effect We have previously shown that siRNAs or adenoviral vector-encoded artificial micro RNAs (amiRNAs) targeting viral mRNAs coding for essential viral DNA synthesis components can inhibit wt Ad5 replication in vitro [21,22]

  • This concentration is in the range of patient serum levels after treatment with typical doses of GCV [36,37,38], and has previously been shown by us to inhibit wt Ad5 replication in cells expressing HSV-TK from AdEE4-TK, while leaving cells not infected with wt

Read more

Summary

Introduction

Human adenoviruses are a frequent threat to immunocompromised patients, and disseminated disease is associated with severe morbidity and mortality. Current drugs are not capable of preventing all fatalities, indicating the need for alternative treatment strategies. Human adenoviruses are double-stranded (ds) DNA viruses that represent a major risk for immunocompromised patients [1,2,3], and severe manifestations of adenoviral infections can be life-threatening. Alternative strategies to treat severe adenovirus infections have been developed. The adoptive transfer of adenovirus-specific T cells represents a promising approach for the treatment of immunocompromised patients [17,18], but its efficacy is still under investigation

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call